Computational analysis of Alzheimer-causing mutations in amyloid precursor protein and presenilin 1.


Journal

Archives of biochemistry and biophysics
ISSN: 1096-0384
Titre abrégé: Arch Biochem Biophys
Pays: United States
ID NLM: 0372430

Informations de publication

Date de publication:
15 12 2019
Historique:
received: 05 09 2019
revised: 25 10 2019
accepted: 02 11 2019
pubmed: 8 11 2019
medline: 27 3 2020
entrez: 8 11 2019
Statut: ppublish

Résumé

Single-point mutations in the genes coding for amyloid precursor protein (APP) and presenilin 1 (PS1), the active subunit of γ-secretase that cleaves APP to produce Aβ, are the main causes of rare but severe familial Alzheimer's disease (fAD). Recent structures of the transmembrane parts of APP and γ-secretase with a fragment of APP bound enable us to study the origins of the pathogenicity of the single amino acid changes in the context of the actual enzyme-substrate complex, which has not previously been possible. We used the new structures as input for several state-of-the-art computational methods that predict the folding stability effect of mutations. We find that pathogenic mutations almost exclusively reduce the stability of the proteins. Since most "random" mutations of an evolutionarily optimized protein tend to destabilize, we also show that the APP mutations destabilize the complex-bound substrate more than the free substrate, indicating reduced affinity of APP to γ-secretase. We confirmed this using two other methods, BEATMUSIC and mCSM PPI, specifically developed for calculating binding affinities of mutants. Although pathogenic PS1 mutations destabilize the complex and substrate-free form to the same extent, they significantly destabilize the protein more than the control set of random mutations. We conclude that fAD mutations most likely reduce the stability of the protein-substrate complex and thus retention time of APP-C99, leading to premature release of longer toxic Aβ

Identifiants

pubmed: 31697913
pii: S0003-9861(19)30779-9
doi: 10.1016/j.abb.2019.108168
pii:
doi:

Substances chimiques

Amyloid beta-Protein Precursor 0
Presenilin-1 0
Amyloid Precursor Protein Secretases EC 3.4.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108168

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Rukmankesh Mehra (R)

DTU Chemistry, Technical University of Denmark, DK-2800, Kongens Lyngby, Denmark.

Kasper P Kepp (KP)

DTU Chemistry, Technical University of Denmark, DK-2800, Kongens Lyngby, Denmark. Electronic address: kpj@kemi.dtu.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH